Literature DB >> 8797719

Transgenic mouse models for HTLV-I infection.

W J Grossman1, L Ratner.   

Abstract

Human T-cell leukemia virus type I (HTLV-I) was the first human retrovirus isolated and is responsible for at least one form of human leukemia. The pathogenic mechanism(s) whereby HTLV transforms T lymphocytes in vivo is(are) obscure due to its long-term latency and the lack of practical representative animal models. The tax gene of HTLV-I has been implicated in this transformation process because of its ability to transactivate several cellular genes associated with T-cell replication and activation. Here, transgenic mouse models are discussed that express the Tax protein of HTLV-I and provide insights into its role in the cellular transformation process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8797719     DOI: 10.1097/00042560-199600001-00025

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  8 in total

1.  HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition.

Authors:  Ling Gao; Hongju Deng; Haibo Zhao; Angela Hirbe; John Harding; Lee Ratner; Katherine Weilbaecher
Journal:  Blood       Date:  2005-08-23       Impact factor: 22.113

2.  Role of post-translational modifications of HTLV-1 Tax in NF-κB activation.

Authors:  Noula Shembade; Edward W Harhaj
Journal:  World J Biol Chem       Date:  2010-01-26

Review 3.  Pathogenesis and treatment of human T-cell leukemia virus infection.

Authors:  Lee Ratner
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

4.  Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors.

Authors:  Dan Rauch; Shimon Gross; John Harding; Stefan Niewiesk; Michael Lairmore; David Piwnica-Worms; Lee Ratner
Journal:  Blood       Date:  2008-10-29       Impact factor: 22.113

5.  HTLV-I Tax-Mediated Inactivation of Cell Cycle Checkpoints and DNA Repair Pathways Contribute to Cellular Transformation: "A Random Mutagenesis Model".

Authors:  Christophe Nicot
Journal:  J Cancer Sci       Date:  2015-09-23

6.  In Vivo Tumorigenesis, Osteolytic Sarcomas, and Tumorigenic Cell Lines from Transgenic Mice Expressing the Human T-Lymphotropic Virus Type 1 (HTLV-1) Tax Viral Oncogene.

Authors:  Lisa G Lanigan; Blake E Hildreth; Wessel P Dirksen; Jessica K Simmons; Chelsea K Martin; Jillian L Werbeck; Nandu K Thudi; Tracey L Papenfuss; Prosper N Boyaka; Ramiro E Toribio; Jerrold M Ward; Katherine N Weilbaecher; Thomas J Rosol
Journal:  Am J Pathol       Date:  2020-11-09       Impact factor: 4.307

7.  T-cell activation promotes tumorigenesis in inflammation-associated cancer.

Authors:  Dan Rauch; Shimon Gross; John Harding; Sirosh Bokhari; Stefan Niewiesk; Michael Lairmore; David Piwnica-Worms; Lee Ratner
Journal:  Retrovirology       Date:  2009-12-17       Impact factor: 4.602

8.  Inducible nitric oxide synthase mediates DNA double strand breaks in Human T-Cell Leukemia Virus Type 1-induced leukemia/lymphoma.

Authors:  Hicham H Baydoun; Mathew A Cherian; Patrick Green; Lee Ratner
Journal:  Retrovirology       Date:  2015-08-12       Impact factor: 4.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.